XML 25 R5.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY
¥ in Thousands, $ in Thousands
CNY (¥)
USD ($)
Ordinary share
CNY (¥)
shares
Treasury Stock
CNY (¥)
shares
Additional paid-in capital
CNY (¥)
Statutory reserve
CNY (¥)
Accumulated other comprehensive income/(loss)
CNY (¥)
Accumulated deficit
CNY (¥)
Total Yunji Inc. shareholders' (deficit)/equity
CNY (¥)
Non- controlling interest
CNY (¥)
Balance at Dec. 31, 2018 ¥ (4,110,455)   ¥ 36     ¥ 8,504 ¥ 55,565 ¥ (4,180,922) ¥ (4,116,817) ¥ 6,362
Balance (Shares) at Dec. 31, 2018 | shares     1,151,400,000              
Net (loss)/income (123,834)             (125,762) (125,762) 1,928
Accretion on convertible redeemable preferred shares to redemption value (1,532,013)       ¥ (36,494)     (1,495,519) (1,532,013)  
Appropriation to statutory reserves           3,129   (3,129)    
Issuance of ordinary shares upon Initial Public Offering 737,297   ¥ 4   737,293       737,297  
Issuance of ordinary shares upon Initial Public Offering (Shares) | shares     112,174,470              
Foreign currency translation adjustments 33,298           33,298   33,298  
Conversion of redeemable preferred shares 6,446,060   ¥ 30   6,446,030       6,446,060  
Conversion of redeemable preferred shares (Shares) | shares     895,216,752              
Repurchasing common stock (117,371)     ¥ (117,371)         (117,371)  
Repurchasing common stock (Shares) | shares       (33,829,860)            
Issuance of ordinary shares due to the exercise of share option 1,080     ¥ 5,769 (4,689)       1,080  
Issuance of ordinary shares due to the exercise of share option (Shares) | shares       1,407,920            
Issuance of restricted shares       ¥ 14,933 (14,933)          
Issuance of restricted shares (Shares) | shares       3,036,290            
Capital injection from non-controlling interests 2,400                 2,400
Shared-based compensation 128,197       128,197       128,197  
Balance at Dec. 31, 2019 1,464,659   ¥ 70 ¥ (96,669) 7,255,404 11,633 88,863 (5,805,332) 1,453,969 10,690
Balance (Shares) at Dec. 31, 2019 | shares     2,158,791,222 (29,385,650)            
Net (loss)/income (151,692)             (146,346) (146,346) (5,346)
Appropriation to statutory reserves           6,467   (6,467)    
Foreign currency translation adjustments (79,411)           (79,411)   (79,411)  
Repurchasing common stock (23,171)     ¥ (23,171)         (23,171)  
Repurchasing common stock (Shares) | shares       (6,246,410)            
Issuance of ordinary shares due to the exercise of share option 8,004     ¥ 31,489 (23,485)       8,004  
Issuance of ordinary shares due to the exercise of share option (Shares) | shares       9,151,290            
Issuance of restricted shares       ¥ 3,149 (3,149)          
Issuance of restricted shares (Shares) | shares       954,960            
Capital injection from non-controlling interests 2,300                 2,300
Shared-based compensation 98,378       98,378       98,378  
Disposal of subsidiaries (2,999)         (5,476)   6,060 584 (3,583)
Dividend to non-controlling interest shareholders (1,200)                 (1,200)
Balance at Dec. 31, 2020 1,314,868   ¥ 70 ¥ (85,202) 7,327,148 12,624 9,452 (5,952,085) 1,312,007 2,861
Balance (Shares) at Dec. 31, 2020 | shares     2,158,791,222 (25,525,810)            
Net (loss)/income 132,284 $ 20,757           131,966 131,966 318
Appropriation to statutory reserves           1,395   (1,395)    
Foreign currency translation adjustments (25,116) (3,941)         (25,116)   (25,116)  
Repurchasing common stock (220)     ¥ (220)         (220)  
Repurchasing common stock (Shares) | shares       (387,500)            
Issuance of ordinary shares due to the exercise of share option 480     ¥ 2,124 (1,644)       480  
Issuance of ordinary shares due to the exercise of share option (Shares) | shares       748,730            
Issuance of restricted shares       ¥ 39,070 (39,070)          
Issuance of restricted shares (Shares) | shares       12,908,750            
Capital injection from non-controlling interests 208                 208
Shared-based compensation 55,910       55,910       55,910  
Disposal of subsidiaries 1,560             2,869 2,869 (1,309)
Dividend to non-controlling interest shareholders (261)                 (261)
Balance at Dec. 31, 2021 1,478,515 $ 232,012 ¥ 70 ¥ (44,228) ¥ 7,342,344 ¥ 14,019 ¥ (15,664) ¥ (5,818,645) ¥ 1,477,896 619
Balance (Shares) at Dec. 31, 2021 | shares     2,158,791,222 (12,255,830)            
Acquisition of additional shares in subsidiaries from non-controlling interest shareholders ¥ (1,198)                 ¥ (1,198)